As filed with the Securities and Exchange Commission on July 29, 2024

 

Registration No. 333-

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

VIVOPOWER INTERNATIONAL PLC

(Exact name of registrant as specified in its charter)

 

 

 

England and Wales Not applicable

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

The Scalpel, 18th Floor, 52 Lime Street

London EC3M 7AF
United Kingdom

Telephone: +44 203 667 5158

(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)

VivoPower International PLC 2017 Omnibus Equity Incentive Plan
(Full title of the plan)

 

Corporation Service Company

251 Little Falls Drive Wilmington, DE 19808

United States
+1 302 636 5400

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

 

 

 

EXPLANATORY NOTE

 

On July 6, 2023, the shareholders of VivoPower International PLC (the “Registrant”) approved an amendment to the VivoPower International PLC 2017 Omnibus Incentive Plan (“OIP”) allowing the number of ordinary shares, nominal value $0.12 per share (the “Ordinary Shares”), reserved under the OIP to automatically increase each July 1, beginning on July 1, 2023, and ending on July 2, 2032, by 5.0% of the outstanding number of Ordinary Shares of the Registrant on the immediately preceding June 30, or such lesser amount as determined by the Registrant’s Remuneration Committee (the “Evergreen Provision”).

 

This Registration Statement on Form S-8 (the “Registration Statement”) is being filed to register an additional 221,987 Ordinary Shares of the Registrant to be issued pursuant to the Registrant’s OIP as a result of the Evergreen Provision. This Registration Statement registers additional securities of the same class as other securities for which the registration statements filed on Form S-8 on July 28, 2023, December 8, 2022, December 21, 2020 and October 12, 2018 (File Nos. 333-273520, 333-268720, 333-227810 and 333-251546) are effective (collectively, the “Previous Registration Statements”). The information contained in the Previous Registration Statements is hereby incorporated by reference pursuant to General Instruction E of Form S-8.

 

In accordance with the instructional Note to Part I of Form S-8 as promulgated by the Securities and Exchange Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement on Form S-8 with respect to the Ordinary Shares.

 

 
 

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8. Exhibits.

 

Exhibit

Number

  Exhibit Description  

Filed

Herewith

 

Incorporated by

Reference herein from

Form or Schedule

  Filing Date  

SEC File/

Reg. Number

3.1   Articles of Association of the Registrant.      

Form F-4

  8/24/2016   333-213297
            (Exhibit 3.1)        
                     
4.1   Form of Certificate Evidencing Ordinary Shares.      

Form F-3

  1/12/2024   333-276509
            (Exhibit 4.1)        
                     
5.1   Opinion of Shoosmiths LLP.   X            
                     
23.1   Consent of Independent Registered Public Accounting Firm.   X            
                     
23.2   Consent of Shoosmiths LLP (included in Exhibit 5.1).   X            
                     
24.1   Power of Attorney (included on the signature page hereof).   X            
                     
99.1+   Amended and Restated VivoPower International PLC 2017 Omnibus Incentive Plan (including appendix Sub-Plan for Non-Employees).      

Form S-8

  7/28/2023   333-273520
            (Exhibit 99.1)        
                     
107   Filing Fee Table.   X            

 

+ Denotes management contract or compensatory plan or arrangement

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of London, United Kingdom, on July 29, 2024.

 

  VIVOPOWER INTERNATIONAL PLC
   
  By: /s/ Kevin Chin
   

Kevin Chin

Chief Executive Officer, Executive Chairman and Director

 

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Kevin Chin and Gary Challinor, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Kevin Chin   Chief Executive Officer, Executive Chairman and Director   July 29, 2024
Kevin Chin   (Principal Executive Officer)    
         
/s/ Gary Challinor   Chief Financial Officer   July 29, 2024
Gary Challinor   (Principal Financial and Accounting Officer)    
         
/s/ Michael Hui   Director   July 29, 2024
Michael Hui        
         
/s/ Peter Jeavons   Director   July 29, 2024
Peter Jeavons        
         
/s/ William Langdon   Director   July 29, 2024
William Langdon        

 

 

 

 

SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE OF THE REGISTRANT

 

Pursuant to the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of VivoPower International PLC has signed this registration statement on July 29, 2024.

 

  VIVOPOWER INTERNATIONAL PLC
     
  By: /s/ William Langdon
  Name: William Langdon
  Title: Director

 

 

 

 

Exhibit 5.1

 

 

VivoPower International PLC  
The Scalpel  
18th Floor  
52 Lime Street  
London  
EC3M 7AF  
     
Our Ref ATP/M-00908237  
Date 29 July 2024  

 

Dear Sirs

 

VivoPower International PLC Registration Statement on Form S-8

 

We have acted as counsel to VivoPower International PLC (company number 09978410) (“Company”), a public limited company incorporated in England and Wales, in connection with the matters set out below.

 

For the purposes of our opinion, we have examined and relied upon such documents, records, certificates and other instruments as we, in our professional judgment, have deemed necessary or appropriate as a basis for the opinions and statements below.

 

1Scope of opinion

 

1.1The opinions given in this Opinion Letter (the “Opinions”) are given only with respect to English law as published and applied by the courts of England and Wales at the date of this Opinion Letter.

 

1.2We express no opinion on the laws of any other jurisdiction. No opinion is expressed as to any provision of the Documents (as defined below) that refers to specific laws or regulations of any jurisdiction other than England and Wales. To the extent that the laws of the United States of America or any other jurisdiction may be relevant to the subject matter of the Opinions, we have made no independent investigation of them and our opinion is subject to the effect of such laws. We express no opinion on the validity of such matters.

 

1.3The Opinions are given only with respect to the matters expressly set out in paragraph 4.1 and shall not be construed as opinions as to any other matter. The Opinions do not cover the matters set out in paragraph 6.1.

 

1.4The Opinions are given on the basis of the assumptions set out in paragraph 5. We have not taken any steps to investigate whether they are correct except as may be specified in paragraph 5.

 

1.5The Opinions are subject to the qualifications listed in paragraph 6 and to any matters not disclosed to us.

 

1.6By providing you with this Opinion Letter, we do not assume any obligation to notify you of future changes in law which may affect the Opinions or to otherwise update this Opinion Letter in any respect.

 

 

 

 

 

2Background

 

2.1We have acted as English legal advisers to VivoPower International PLC, a public limited company incorporated in England and Wales, in connection with the registration statement on Form S-8 which is attached to this Opinion Letter as an exhibit (the “Registration Statement”) filed with the United States Securities and Exchange Commission (the “SEC”) pursuant to the United States Securities Act of 1933, as amended (the “Securities Act”).

 

2.2The Registration Statement relates to an increase of 221,987 shares available for issuance by the Company from time to time of ordinary shares each having a nominal value of $0.12 pursuant to the Company’s 2017 Omnibus Equity Incentive Plan (the “Plan”) which was implemented in a general meeting of the Company held on 5 September 2017 (the “New Shares”).

 

2.3We understand that none of the New Shares are, and are not intended to be, admitted to trading on any market or exchange, or otherwise listed, in the United Kingdom.

 

3Examination of documents and searches

 

3.1For the purpose of giving this Opinion Letter, we have examined the following documents (the “Documents”, each a “Document”):

 

3.1.1the final copy Registration Statement;

 

3.1.2copy of the Company’s certificate of incorporation dated 1 February 2016 and copy current articles of association adopted pursuant to a special resolution of the Company’s shareholders passed on 20 August 2018;

 

3.1.3a minute of the general meeting of the Company held on 5 September 2017 at which certain shareholder resolutions were passed, including the resolution to approve the Plan and the resolution providing a general authority to allot shares in the Company and disapplying statutory pre-emption rights in respect of such allotment of shares or the grant of rights to subscribe for or convert into shares up to an aggregate nominal value of $1,560.00;

 

3.1.4the final copy registration statement on Form S-8 dated 12 October 2018 which registered 1,355,736 ordinary shares of $0.012 pursuant to the Plan;

 

3.1.5the final copy registration statement on Form S-8 dated 21 December 2020 which registered 338,237 ordinary shares of $0.012 pursuant to the Plan;

 

3.1.6the final copy registration statement on Form S-8 dated 8 December 2022 which registered 958,421 ordinary shares of $0.012 pursuant to the Plan;

 

3.1.7written resolutions of the board of directors passed on 9 October 2020 which resolved to approve the allotment of ordinary shares of $0.012 each up to an aggregate subscription amount of $34,500,000;

 

3.1.8written resolutions of the board of directions passed on 14 October 2020 which resolved to approve the allotment of ordinary shares of $0.012 each up to an aggregate offering price of $5,750,000;

 

3.1.9a minute of the general meeting of the Company held on 6 October 2020 at which certain shareholder resolutions were passed, including the resolutions providing a general authority to allot shares in the Company and disapplying statutory pre-emption rights in respect of such allotment of shares or the grant of rights to subscribe for or convert into shares up to an aggregate nominal value of $180,000;

 

 

 

 

3.1.10resolutions of the general meeting of the Company held on 10 November 2022 at which certain shareholder resolutions were passed, including the resolutions providing a general authority to allot shares in the Company and disapplying statutory pre-emption rights in respect of such allotment of shares or the grant of rights to subscribe for or convert into shares up to an aggregate nominal value of $180,000;

 

3.1.11a minute of the general meeting of the Company held on 18 December 2020 at which certain shareholder resolutions were passed, including the resolutions providing a general authority to allot ordinary shares in the Company and disapplying statutory pre-emption rights in respect of such allotment of ordinary shares or the grant of rights to subscribe for or convert into ordinary shares up to an aggregate nominal value of $180,000;

 

3.1.12written resolutions of the board of directors of the Company passed on 12 November 2021 which resolved to approve the filing of the Prospectus Supplement (as defined in the Equity Distribution Agreement) with the Commission (as defined in the Equity Distribution Agreement), and written resolutions of the board of directors passed on 12 November 2021 which resolved to approve the allotment and disapplying statutory pre-emption rights in respect of the allotment of ordinary shares up to a subscription amount of $80,000,000;

 

3.1.13a director’s certificate dated 12 November 2021 in which the directors confirmed no resolutions have been passed which render any part of this Opinion Letter untrue or invalid, and that no resolutions of the board or shareholders have been passed to terminate, amend or vary the equity distribution agreement dated 12 November 2021 made between the Company and Alliance Global Partners, as amended by that certain amendment no. 1 to the equity distribution agreement, dated 29 July 2022 (the “Equity Distribution Agreement”), or prevent it being fulfilled in accordance with its terms, and that there are no orders, judgements or other agreements which do the same;

 

3.1.14shareholder resolutions passed on 6 July 2023 providing authority for the directors to consolidate and divide all of the Company’s existing ordinary shares of $0.012 each into such reduced number of ordinary shares of such increased nominal value as the Company’s board may determine at any time prior to 23 October 2023;

 

3.1.15written resolutions of the board of directors of the Company passed on 27 July 2023 which resolved to approve the filing of the Registration Statement with the Securities and Exchange Commission;

 

3.1.16written resolutions of the board of directors passed on 2 October 2023 which resolved to approve the consolidation of the Company’s existing ordinary shares of $0.012 each into 2,578,826 ordinary shares of $0.12 each;

 

3.1.17a minute of the general meeting of the Company held on 28 December 2023 at which certain shareholder resolutions were passed, including the resolutions providing a general authority to allot ordinary shares of $0.12 each in the capital of the Company and disapplying statutory pre-emption rights in respect of such allotment of ordinary shares or the grant of rights to subscribe for or convert into ordinary shares up to an aggregate nominal value of $3,600,000;

 

 

 

 

3.1.18written resolutions of the board of directors of the Company passed on 25 July 2024 which resolved to approve the filing of the Registration Statement with the Securities and Exchange Commission;

 

3.1.19a directors’ certificate dated 26 July 2024 in relation to the ordinary shares of the Company to be issued pursuant to the Company’s 2017 Omnibus Incentive Plan including, amongst other things, confirmation that there is sufficient authority pursuant to prior shareholder resolutions that have been passed to allot the New Shares;

 

3.1.20a certificate of good standing of the Company dated 22 July 2024;

 

3.1.21at 11.10am on 26 July 2024 an online search of the public records on file and available for inspection at Companies House in respect of the Company; and

 

3.1.22at 13:46 on 25 July 2024 an online search of the Central Registry of Winding-up Petitions at the Insolvency and Companies List (formerly the Companies Court) in London in respect of the Company.

 

3.2Except as stated above, we have not examined any other documents or corporate or other records and we have not made any other searches, enquiries or investigations for the purpose of giving the Opinions.

 

4Opinions

 

4.1Based on and subject to the qualifications, assumptions and limitations set out in this Opinion Letter and subject to any matters not disclosed to us, we are of the opinion that:

 

4.1.1the Company is a public limited company duly incorporated under English law, noting that our searches undertaken on 26 July 2024 revealed no order or resolution for the winding-up of the Company and no notice of the appointment of a receiver, administrative receiver or administrator in respect of it or any of its assets; and

 

4.1.2the New Shares will, when issued and delivered in accordance with the terms of the Plan and when the names of the holders of such New Shares or their nominees are entered into the register of members of the Company and subject to the receipt by the Company of the aggregate issue price in respect of all the New Shares, be validly issued, fully paid and no further amount may be called thereon.

 

4.2The opinions in paragraph 4.1 are given only for the benefit of VivoPower International PLC and they may not be relied upon by any other person or for any other purpose.

 

4.3No person who is permitted to rely on this Opinion Letter may assign it to, or hold the benefit of it on trust for, any other person.

 

4.4These Opinions may not be disclosed to any person, or quoted in any public document, or otherwise made public in any way, without our prior written consent, except as follows, on a non-reliance basis:

 

4.4.1where disclosure is required or requested by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any relevant stock exchange or pursuant to any applicable law or regulation; or

 

4.4.2where disclosure is required in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes,

 

but in each case only on the condition that: (i) such disclosure is made only to enable any such person to be informed that an opinion has been given and to be made aware of its terms; (ii) we do not assume any duty or liability to any person to whom such disclosure is made; (iii) the recipient is informed of the confidential nature of this opinion; and (iv) the recipient may not disclose this opinion to any other person.

 

 

 

 

4.5Our liability under this Opinion Letter is limited to $3,000,000 for any one claim or series of claims arising out of this Opinion Letter.

 

4.6The Opinions are given only by Shoosmiths LLP, an English limited liability partnership, and no partner, member or employee shall have any personal responsibility or owe any duty of care in relation to it.

 

4.7We consent to the filing of this Opinion Letter to the Registration Statement subject to paragraph 4.2 above (and without creating any assumption of duty on our part to any person other than the Company). In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

 

5assumptions

 

5.1Documents

 

We have assumed:

 

5.1.1the genuineness of all signatures and seals on the Documents (or on the relevant originals where we have examined copies) and the authenticity and completeness of those Documents;

 

5.1.2the conformity to the original Documents of any Documents submitted to us as certified or uncertified copies or scans of the original Documents; and

 

5.1.3that there have been no variations to any of the Documents provided to us or to the originals thereof and none of the Documents have been superseded or rescinded.

 

5.2Other parties and laws

 

In relation to the parties to the Documents and all laws other than those of England and Wales we have assumed:

 

5.2.1the capacity, power and authority to execute and the due execution of the Documents by each party to it (other than the Company as a matter of English law);

 

5.2.2that the obligations expressed to be assumed by each party to the Documents other than the Company are valid and legally binding upon them (as a matter of English law);

 

5.2.3that all obligations under the Documents are valid, legally binding upon, and enforceable against, the parties thereto as a matter of all relevant laws other than the laws of England and Wales;

 

5.2.4due compliance by all relevant parties other than the Company with all matters (including, without limitation, the making of necessary filings, lodgements, registrations and notifications and the payment of stamp duties and other documentary taxes and charges) that govern or relate to the Documents or such parties;

 

 

 

 

5.2.5where any consents, directions, authorisations, approvals or instructions have to be obtained under any law, regulation or practice for the performance of the Documents (other than any corporate authorisations, approvals and company law requirements the subject of this letter), they have been obtained or that they will be forthcoming within any relevant period in order to be fully effective for such purpose; and

 

5.2.6other than European Union Law as it affects the laws of England and Wales, there are no laws of any jurisdiction outside England and Wales which would, or might, affect the Opinions.

 

5.3Corporate actions and status

 

In relation to the Company, we have assumed:

 

5.3.1that each resolution of the directors and shareholders of the Company certified as being true and accurate and provided to us in connection with the giving of the Opinions was duly passed by the required majority at a properly convened and quorate meeting of directors (or a duly authorised committee thereof) and of shareholders of the Company or otherwise in accordance with the constitutional documents of the Company and/or the Companies Act 2006;

 

5.3.2that each person identified as a director or a secretary in any resolution of the directors of the Company was validly appointed as such and was in office at the date of the Documents;

 

5.3.3that any provisions contained in the Companies Act 2006 and/or the articles of association of the Company relating to the declaration of directors’, interests or the power of interested directors to vote were duly observed;

 

5.3.4that any restrictions in the articles of association of the Company on that Company’s and/or on its directors’ authority to guarantee will not be contravened by the entry into and performance by it of the Documents to which it is a party;

 

5.3.5that the execution and delivery of the Documents by the Company and the exercise of its rights and performance of its obligations under the Documents will promote the success of the Company for the benefit of its members as a whole;

 

5.3.6that no step has been taken to wind up the Company nor to appoint a receiver, administrator or like officer in respect of the Company or any of its assets and that no voluntary arrangement has been proposed in respect of the Company; and

 

5.3.7there are no agreements, letters or other arrangements having contractual effect which modify the terms of, or affect, the Documents or which render the Company incapable of or prohibit it from performing any of its obligations under the Documents and no provision of the Documents have been waived and there are no contractual or similar restrictions contained in any agreement or arrangement (other than the Documents) which are binding on the Company which would prohibit it from performing any of its obligations under the Documents.

 

5.4Reliance on Documents

 

5.4.1All Documents submitted to us as copies or certified copies are true copies of the originals and such originals and all Documents submitted to us as originals are genuine and complete and all signatures (including electronic signatures), stamps and seals on the documents are genuine.

 

 

 

 

5.4.2Each Document accurately records the agreement of the parties to it and has not been amended, varied, waived, superseded, rescinded, breached, revoked or terminated.

 

5.4.3The Documents are in the form produced to the directors of the Company.

 

5.4.4There have been no amendments to the articles of association of the Company since the date referred to in paragraph 3.1.2.

 

5.5Execution

 

5.5.1The Documents have been signed by or on behalf of each party to it by person(s) authorised by the relevant party to (in the presence of a witness where applicable).

 

5.5.2The making of the signatures on the signature pages to the Documents was made or done in a manner recognised by law as valid and the Documents have remained intact since those signatures were made or affixed (as the case may be).

 

5.5.3The Documents have been dated with the date on which it was signed and duly delivered by the parties to it (where applicable).

 

5.6Searches

 

5.6.1The information disclosed in response to the searches referred to in paragraph 3.1 of this Opinion Letter was accurate, complete and up to date at the time of those searches and those responses did not fail to disclose any matters which they should have disclosed and which were relevant for the purposes of this Opinion Letter. Since the date of those searches and enquiries there has been no alteration in the status of the Company as revealed in those searches.

 

5.6.2No event has occurred in relation to the Company, such as the passing of a resolution for or the presentation of a petition or the taking of any other action for the winding-up of, or the appointment of a liquidator, administrator, administrative receiver or receiver of the Company, in respect of which a filing at the Companies Registry or at the Central Index of the Companies Court was required to be made and has not been made or has been made but has not at the date of the searches appeared on the relevant search result relating to the Company.

 

5.7Other matters

 

5.7.1None of the parties to the Documents are or will be seeking to achieve any purpose not apparent from the Documents which might render any of the Documents illegal or void.

 

5.7.2Where any liability or obligation or right or benefit of a party to the Documents are dependent upon the satisfaction of conditions precedent, those conditions have been or will be duly and properly satisfied.

 

5.7.3There is no other matter or document which would, or might, affect the Opinions and which was not revealed by the Documents.

 

 

 

 

6Qualifications

 

6.1Matters not covered

 

6.1.1We express no opinion as to matters of fact, opinion or intention.

 

6.1.2No opinion is expressed as to any provision of the Documents to the extent it purports to declare or impose a trust, turnover or similar arrangement in relation to any payments or assets received.

 

6.1.3Except to the extent expressly set out in the Opinions, we express no opinion as to any taxation, financial or accountancy matters or any liability to tax which may arise or be suffered as a result of, or in connection with, the Documents or any transaction relating to them.

 

6.1.4We have not investigated the tax affairs of the Company and the Opinion is subject to the general tax laws of the United Kingdom.

 

6.1.5We express no opinion on immunity including the existence, scope, nature and waiver of it or any entitlement to claim immunity from suit or enforcement of the Company and any consequences of such entitlement on its obligations under, or the enforceability of, the Documents.

 

6.2Insolvency

 

6.2.1The validity, performance and enforcement of the Documents may be limited by bankruptcy, insolvency, liquidation, reorganisation or prescription or similar laws of general application relating to or affecting the rights of creditors.

 

6.2.2Any provision in the Documents which confers, purports to confer or waives a right of set-off or similar right may be ineffective against a liquidator or creditor.

 

6.2.3A power of attorney may, in limited circumstances, be revoked by the winding-up or dissolution of the donor company.

 

6.2.4The searches and enquiries referred to in paragraph 3 of this Opinion Letter are not conclusively capable of revealing whether insolvency or similar procedures, or steps towards them, have been started against the Company.

 

6.3Enforceability

 

6.3.1Remedies such as specific performance or the issue of an injunction are available only at the discretion of the courts of England and Wales according to general principles of equity. Specific performance is not usually granted and an injunction is not usually issued where damages would be an adequate alternative.

 

6.3.2Enforcement of claims arising pursuant to the Documents may become barred under the Limitation Act 1980 or may be subject to a defence of set-off or counterclaim.

 

6.3.3Enforcement may be limited by the provisions of the laws of England and Wales applicable to agreements held to have been frustrated by events happening after execution of a document.

 

6.3.4A party to a contract may be able to avoid its obligations under that contract (and may have other remedies) where it has been induced to enter into that contract by a misrepresentation and the courts of England and Wales will generally not enforce an obligation if there has been fraud.

 

6.3.5In this letter “enforceable” means, in relation to an obligation, that it is of a type which the courts of England and Wales enforce. It does not mean that such obligation will be enforced in all circumstances in accordance with the terms of the relevant Document.

 

 

 

 

6.4Discretion of courts

 

6.4.1The courts of England and Wales may stay proceedings if concurrent proceedings are being brought elsewhere.

 

6.4.2There could be circumstances in which the courts of England and Wales would not treat as conclusive those certificates and determinations which any of the Documents state are to be so treated.

 

6.4.3The question whether or not any provisions of the Documents which may be invalid on account of illegality may be severed from the other provisions thereof in order to save those other provisions would be determined by the courts of England and Wales in their discretion.

 

6.5Choice of law

 

An express choice of the laws of England and Wales will be subject to the discretion of the courts of England and Wales to give effect to the mandatory provisions of law of the country where the obligations arising out of the contract are to be performed insofar as those provisions render performance of the contract unlawful.

 

General

 

6.6We have not investigated the laws of any country other than England and Wales and the Opinions are given only with respect to the laws of England and Wales as at the date of this letter.

 

6.7Where any party to any Document is vested with a discretion or may determine a matter in its opinion, the laws of England and Wales may require that such discretion is exercised reasonably and for a proper purpose and/or that such opinion is formed in good faith based on reasonable grounds.

 

6.8Any provisions excluding liability may be limited by law.

 

7APPLICABLE LAW

 

This Opinion Letter is given on the condition that it will be construed in accordance with English law and that each addressee submits to the jurisdiction of the courts of England and Wales and waives any objection to the exercise of such jurisdiction in relation to any dispute arising out of or in connection with this Opinion Letter.

 

Yours faithfully  
   
/s/ SHOOSMITHS LLP  
   
SHOOSMITHS LLP  
Dated: 29 July 2024  

 

 

 

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Form S-8 of VivoPower International plc of our report dated October 2, 2023 relating to the financial statements of VivoPower International plc, which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

 

/s/ PKF Littlejohn LLP

 

London, England

 

July 25, 2024

 

 

 

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-8

 

(Form Type)

 

VivoPower International PLC

 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security Type  Security Class Title  Fee Calculation Rule  Amount Registered (1)  Proposed Maximum Offering Price Per Unit  Maximum Aggregate Offering Price  Fee Rate  Amount of Registration Fee
Equity  Ordinary Shares, nominal value $0. 12 per share  457(c) and 457(h)   221,987   $2.555 (2)  $567,176.785   $0.00014760   $83.72 
Total Offering Amounts          $ 567,176.785        $83.72 
Total Fee Offsets                     -   
Net Fee Due                    $83.72 

 

(1) Represents ordinary shares, nominal value $0.12 per share (the “Ordinary Shares”) that may be issued under the Amended and Restated VivoPower International PLC 2017 Omnibus Equity Incentive Plan (the “Plan”). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional Ordinary Shares that become issuable under the Plan as a result of any stock dividend, stock split, recapitalization or similar transaction effected without the Registrant’s receipt of consideration which would increase the number of outstanding Ordinary Shares.

 

(2) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) promulgated under the Securities Act on the basis of the average of the high and the low price of Registrant’s Common Stock as reported on The Nasdaq Capital Market on July 26, 2024.

 

 

 


VivoPower (NASDAQ:VVPR)
過去 株価チャート
から 6 2024 まで 7 2024 VivoPowerのチャートをもっと見るにはこちらをクリック
VivoPower (NASDAQ:VVPR)
過去 株価チャート
から 7 2023 まで 7 2024 VivoPowerのチャートをもっと見るにはこちらをクリック